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Methods S1. Genotyping and Quality Control 
DNA from 8,122 individuals was extracted from saliva and buccal cheek swab 
samples and hybridized to HumanOmniExpressExome-8v1.2 genotyping arrays at 
the Institute of Psychiatry, Psychology and Neuroscience Genomics & Biomarker 
Core Facility. Raw image data were pre-processed in GenomeStudio according to 
Illumina Exome Chip SOP v1.4. 
(http://confluence.brc.iop.kcl.ac.uk:8090/display/PUB/Production+Version%3A+Illumi
na+Exome+Chip+SOP+v1.4) . Prior to genotype calling, 919 multimapping SNPs and 
501 samples with call rate <0.95 were removed. Following initial QC, the program 
ZCALL was used to augment genotype calling. 
  
DNA from 3,747 individuals was extracted from buccal cheek swabs and genotyped 
at Affymetrix, Santa Clara, California, USA. From the extracted DNA samples, 3,665 
samples were successfully hybridized to AffymetrixGeneChip 6.0 SNP genotyping 
arrays 
(http://www.affymetrix.com/support/technical/datasheets/genomewide_snp6_datashe 
et.pdf) using experimental protocols recommended by the manufacturer. 
 
Raw image data were pre-processed at the Wellcome Trust Sanger Institute, 
Hinxton, UK for genotyping as part of the Wellcome Trust Case Control Consortium 2 
(https://www.wtccc.org.uk/ccc2/). All pre-processing was conducted according to the 
manufacturer’s guidelines 
(http://www.affymetrix.com/support/downloads/manuals/genomewidesnp6_manual.p
df). Following initial QC, the program CHIAMO was used for genotype calling 
(https://mathgen.stats.ox.ac.uk/genetics_software/chiamo/chiamo.html). 
  
After initial quality control, the same quality control was performed on samples from 
each of the platforms (Illumina and Affymetrix) separately using PLINK(Purcell et al., 
2007), R(Team, 2015) and BCFtools(Li, 2011) and EIGENSOFT(Patterson, Price, & 
Reich, 2006; Price et al., 2006).  
 
DNA samples were excluded from subsequent analyses on the basis of call rate 
(<0.98) suspected non-European ancestry, the presence of severe medical or 
psychiatry problems or severe medical complications during early gestation and 
relatedness other than dizygotic twin status. SNPs were excluded if the minor allele 
frequency was <0.5%, if more than 2% of genotype data were missing, or if the 
Hardy Weinberg p-value was lower than 10-5. Non-autosomal markers and indels 
were also removed. Association between SNP and the platform, batch, plate or well 
on which samples were genotyped was calculated; SNPs with an effect p-value < 10-
4 were excluded. 
 
A total sample of 10,346 samples, including 7,026 unrelated individuals from which 
3,320 individuals had a genotyped dizygotic co-twin remained. Genotype data 
following quality control was available for 4,776 individuals and 559,772 SNPs from 
the illumine array and 2,250 individuals and 635,269 SNPs from the Affymetrix array. 
 
Genomewide genotypes from the two arrays were separately phased using 
EAGLE2(Loh et al., 2016) and imputed using the Haplotype Reference Consortium 
(McCarthy et al., 2016) using the Positional Burrows-Wheeler Transform method 
(Durbin, 2014) and the imputation software Minimac3 1.0.13 (Fuchsberger, Abecasis, 
& Hinds, 2015), which are available from the Michigan Imputation Server 
(https://imputationserver .sph.umich.edu). A series of quality checks were performed 
before merging data from the two arrays and variants with info <0.75 were excluded 
and SNPs that were non-overlapping between platforms were removed.  
 
After merging, minor allele frequency differences were tested for between platforms 
and SNPS with an effect p-value <10-4 were removed. Those SNPs with a Hardy 
Wedinberg p-value >10-5  were also removed. Following these criteria, 7,363,646 
genotyped and well-imputed SNPs were retained for analyses. Only unrelated 
individuals were included in the present analyses. To ease high computational 
demands by the software LDpred(Vilhjálmsson et al., 2015) for polygenic scoring in 
large samples, we further excluded SNPs with info <1, leaving 515,100 SNPs for 
analysis. 
 
Methods S2. Creating polygenic scores using LDpred 
 
Genome wide polygenic scores were calculated using the Bayesian approach, 
LDpred, which has been shown to outperform predictive accuracy of the conventional 
clumping and p-value thresholding approach (Vilhjálmsson et al., 2015). Here, a 
posterior effect size is derived for each SNP by re-weighting the original summary 
statistic coefficient by the relative influence of a SNP given its level of linkage 
disequilibrium with surrounding SNPS and a prior on the effect size of each SNP. 
The prior is based on the heritability of the trait and the fraction of markers assumed 
to casually influence the trait. GPS is then calculated as the sum of the trait-
increasing alleles weighted by their posterior effect size estimate. Unlike the 
conventional clumping and thresholding approach, LDpred retains all SNPs common 
between GWA summary statistics and genotype data in the target sample.  
 
For the present study we applied a causal fraction of 1, which assumes that all SNPs 
contribute to the development of the trait. Due to the high computational demand of 
LDpred, especially in larger sample sizes including many SNPs, we made further 
restrictions to our analyses, only including the 515, 100 SNPs that were perfectly 
imputed (info score of 1) to reduce analytical load. Only genotypes of unrelated 
individuals were used to estimate LD structure in our sample because levels of LD 
are considerably higher in relatives compared to unrelated individuals (Vattikuti, Guo, 




Durbin, R. (2014). Efficient haplotype matching and storage using the positional 
Burrows–Wheeler transform (PBWT). Bioinformatics, 30(9), 1266-1272.  
Fuchsberger, C., Abecasis, G. R., & Hinds, D. A. (2015). minimac2: faster genotype 
imputation. Bioinformatics, 31(5), 782-784.  
Li, H. (2011). A statistical framework for SNP calling, mutation discovery, association 
mapping and population genetical parameter estimation from sequencing 
data. Bioinformatics, 27(21), 2987-2993.  
Loh, P.-R., Danecek, P., Palamara, P. F., Fuchsberger, C., Reshef, Y. A., Finucane, 
H. K., . . . Abecasis, G. R. (2016). Reference-based phasing using the 
Haplotype Reference Consortium panel. Nature genetics, 48(11), 1443.  
McCarthy, S., Das, S., Kretzschmar, W., Durbin, R., Abecasis, G., & Marchini, J. 
(2016). A reference panel of 64,976 haplotypes for genotype imputation. 
bioRxiv.  
Patterson, N., Price, A. L., & Reich, D. (2006). Population structure and 
eigenanalysis. PLoS genetics, 2(12), e190.  
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & 
Reich, D. (2006). Principal components analysis corrects for stratification in 
genome-wide association studies. Nature genetics, 38(8), 904.  
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A., Bender, D., . . . 
Sham, P. C. (2007). PLINK: a tool set for whole-genome association and 
population-based linkage analyses. The American Journal of Human 
Genetics, 81(3), 559-575.  
Team, R. C. (2015). R: A language and environment for statistical computing 
[Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2014. 
Vattikuti, S., Guo, J., & Chow, C. C. (2012). Heritability and genetic correlations 
explained by common SNPs for metabolic syndrome traits. PLoS genetics, 
8(3), e1002637.  
Vilhjálmsson, B. J., Yang, J., Finucane, H. K., Gusev, A., Lindström, S., Ripke, S., . . 
. Do, R. (2015). Modeling linkage disequilibrium increases accuracy of 
polygenic risk scores. The american journal of human genetics, 97(4), 576-
592.   
